Praxis Precision Medicines, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74006W2070
USD
294.11
-4.2 (-1.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Assertio Holdings, Inc.
IGM Biosciences, Inc.
Akebia Therapeutics, Inc.
scPharmaceuticals, Inc.
Y-mAbs Therapeutics, Inc.
Enanta Pharmaceuticals, Inc.
Ocular Therapeutix, Inc.
AC Immune SA
Praxis Precision Medicines, Inc.
Lifecore Biomedical, Inc.
AEON Biopharma, Inc.

Why is Praxis Precision Medicines, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Praxis Precision Medicines, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Praxis Precision Medicines, Inc.
692.32%
3.16
197.80%
S&P 500
16.12%
0.84
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-226.69%
EBIT to Interest (avg)
-167.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.67
EV to EBIT
-24.20
EV to EBITDA
-24.21
EV to Capital Employed
28.31
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-116.95%
ROE (Latest)
-34.54%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(HY)

Higher at USD -162.84 MM

ROCE(HY)

Highest at -45.83%

CASH AND EQV(HY)

Highest at USD 866.49 MM

-24What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -249.07 MM

OPERATING PROFIT(Q)

Lowest at USD -97.02 MM

PRE-TAX PROFIT(Q)

Lowest at USD -88.91 MM

NET PROFIT(Q)

Lowest at USD -88.91 MM

RAW MATERIAL COST(Y)

Grown by 101.02% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -68.24 %

EPS(Q)

Lowest at USD -3.5

Here's what is working for Praxis Precision Medicines, Inc.

Cash and Eqv
Highest at USD 866.49 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Praxis Precision Medicines, Inc.

Operating Cash Flow
Lowest at USD -249.07 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -97.02 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -88.91 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -88.91 MM has Fallen at -30.26%
over average net sales of the previous four periods of USD -68.26 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -88.91 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Profit
At USD -88.91 MM has Fallen at -30.26%
over average net sales of the previous four periods of USD -68.26 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

EPS
Lowest at USD -3.5
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio
Highest at -68.24 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 101.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales